Scuteri Arianna, Donzelli Elisabetta
Experimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza 20900, Italy.
World J Stem Cells. 2024 Dec 26;16(12):1002-1011. doi: 10.4252/wjsc.v16.i12.1002.
Extracellular vesicles (EVs) are cell-to-cell interaction tools that are attracting increasing interest in the literature in two opposing areas. In addition to their role in physiological development, there is growing evidence of their involvement in healing and protective processes. However, EVs also mediate pathological conditions, particularly contributing to the progression of several chronic diseases, such as neurodegenerative diseases. On the other hand, EVs also form the core of a new therapeutic strategy for neuroprotection, which is based on the administration of EVs derived from a wide range of donor cells. In particular, the possibility of obtaining numerous EVs from stem cells of different origins, which is feasible for therapeutic aims, is now under investigation. In this review, we focused on neurodegenerative diseases, in which EVs could have a propagative detrimental effect or could also be exploited to deliver protective factors. This review explores the different hypotheses concerning the dual role of EVs, with the aim of shedding light on the following question: Can vesicles be used to fight vesicle-propagated diseases?
细胞外囊泡(EVs)是细胞间相互作用的工具,在两个相反的领域正吸引着文献中越来越多的关注。除了它们在生理发育中的作用外,越来越多的证据表明它们参与愈合和保护过程。然而,EVs也介导病理状况,特别是促成几种慢性疾病的进展,如神经退行性疾病。另一方面,EVs也构成了一种新的神经保护治疗策略的核心,该策略基于施用源自多种供体细胞的EVs。特别是,从不同来源的干细胞获得大量EVs用于治疗目的的可能性目前正在研究中。在这篇综述中,我们聚焦于神经退行性疾病,其中EVs可能具有传播性有害作用,或者也可被用于递送保护因子。这篇综述探讨了关于EVs双重作用的不同假说,目的是阐明以下问题:囊泡能否用于对抗由囊泡传播的疾病?